Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Mkaddem, Sanae Ben ^a,b,c,d   Murua, Amaya ^a,b,c,d   Flament, Héloise ^a,b,c,d,e   Titeca Beauport, Dimitri ^a,b,c,d   Bounaix, Carine ^a,b,c,d   Danelli, Luca ^a,b,c,d   Launay, Pierre ^a,b,c,d   Benhamou, Marc ^a,b,c,d   Blank, Ulrich ^a,b,c,d   Daugas, Eric ^a,b,c,d,e   Charles, Nicolas ^a,b,c,d   Monteiro, Renato C ^a,b,c,d,e  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Laboratory of Excellence Labex INFLAMEX   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 1; LYN PROTEIN-TYROSINE KINASE; PROTEIN TYROSINE KINASE;

ABNORMALITY; ENZYME ACTIVITY; GENE EXPRESSION; HOMEOSTASIS; INHIBITOR; LIGAND; MOLECULAR ANALYSIS; PROTEIN; RODENT;

ANIMAL TISSUE; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOLOGY; MALE; PHOSPHORYLATION;

MUS;

ANIMALS; FEMALE; HOMEOSTASIS; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FYN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 85027521309     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00294-0     Document Type: Article

References (49)

1. Bezbradica, J. S. & Medzhitov, R. Role of ITAM signaling module in signal integration. Curr. Opin. Immunol. 24, 58-66 (2012).
2. Hamerman, J. A. & Lanier, L. L. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006, re1 (2006).
3. Reth, M. Antigen receptor tail clue. Nature 338, 383-384 (1989).
4. Hogarth, P. M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 14, 798-802 (2002).
5. Getahun, A. & Cambier, J. C. Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol. Rev. 268, 66-73 (2015).
6. Bolland, S. & Ravetch, J. V. Inhibitory pathways triggered by ITIM-containing receptors. Adv. Immunol. 72, 149-177 (1999).
7. Pasquier, B. et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 22, 31-42 (2005).
8. Pinheiro da Silva, F. et al. CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13, 1368-1374 (2007).
9. Kanamaru, Y. et al. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. J. Immunol. 180, 2669-2678 (2008).
10. Aloulou, M. et al. IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses. Blood 119, 3084-3096 (2012).
11. Ben Mkaddem, S. et al. Shifting FcgammaRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J. Clin. Invest. 124, 3945-3959 (2014).
12. Iborra, S. et al. Leishmania uses mincle to target an inhibitory ITAM signaling pathway in dendritic cells that dampens adaptive immunity to infection. Immunity 45, 788-801 (2016).
13. Blank, U., Launay, P., Benhamou, M. & Monteiro, R. C. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232, 59-71 (2009).
14. Mkaddem, S. B. et al. IgA, IgA receptors, and their anti-inflammatory properties. Curr. Top. Microbiol. Immunol. 382, 221-235 (2014).
15. Stefanova, I. et al. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4, 248-254 (2003).
16. Getahun, A., Beavers, N. A., Larson, S. R., Shlomchik, M. J. & Cambier, J. C. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J. Exp. Med. 213, 751-769 (2016).
17. Abram, C. L., Roberge, G. L., Pao, L. I., Neel, B. G. & Lowell, C. A. Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity 38, 489-501 (2013).
18. Croker, B. A. et al. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc. Natl Acad. Sci. USA 105, 15028-15033 (2008).
19. Pao, L. I. et al. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27, 35-48 (2007).
20. Johnson, D. J. et al. Shp1 regulates T cell homeostasis by limiting IL-4 signals. J. Exp. Med. 210, 1419-1431 (2013).
21. Iwashima, M., Irving, B. A., van Oers, N. S., Chan, A. C. & Weiss, A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263, 1136-1139 (1994).
22. Gauld, S. B. & Cambier, J. C. Src-family kinases in B-cell development and signaling. Oncogene 23, 8001-8006 (2004).
23. Hibbs, M. L. et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311 (1995).
24. Janas, M. L., Hodgkin, P., Hibbs, M. & Tarlinton, D. Genetic evidence for Lyn as a negative regulator of IL-4 signaling. J. Immunol. 163, 4192-4198 (1999).
25. Nishizumi, H. et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3, 549-560 (1995).
26. Kraus, M. et al. Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail. J. Exp. Med. 194, 455-469 (2001).
27. Jones, M. L., Craik, J. D., Gibbins, J. M. & Poole, A. W. Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus. J. Biol. Chem. 279, 40475-40483 (2004).
28. Liu, Y., Kruhlak, M. J., Hao, J. J. & Shaw, S. Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity. J. Leukoc. Biol. 82, 742-751 (2007).
29. Tan Sardjono, C. et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum. 52, 3220-3229 (2005).
30. Parravicini, V. et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3, 741-748 (2002).
31. Daniels, A. B. et al. Analysis of FcgammaRIIA cytoplasmic tail requirements in signaling for serotonin secretion: evidence for an ITAM-dependent, PI3K-dependent pathway. Scand. J. Immunol. 71, 232-239 (2010).
32. Rossato, E. et al. Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 inhibitory pathway. Arthritis Rheumatol. 67, 1766-1777 (2015).
33. O'Neill, S. K. et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35, 746-756 (2011).
34. Fitzer-Attas, C. J. et al. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191, 669-682 (2000).
35. Kovacs, M. et al. The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J. Exp. Med. 211, 1993-2011 (2014).
36. Zhang, Z., Shen, K., Lu, W. & Cole, P. A. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J. Biol. Chem. 278, 4668-4674 (2003).
37. Lesourne, R., Bruhns, P., Fridman, W. H. & Daeron, M. Insufficient phosphorylation prevents fc gamma RIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 276, 6327-6336 (2001).
38. Pfirsch-Maisonnas, S. et al. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Sci. Signal. 4, ra24 (2011).
39. Chaimowitz, N. S., Falanga, Y. T., Ryan, J. J. & Conrad, D. H. Fyn kinase is required for optimal humoral responses. PLoS ONE 8, e60640 (2013).
40. Rascu, A., Repp, R., Westerdaal, N. A., Kalden, J. R. & van de Winkel, J. G. Clinical relevance of Fc gamma receptor polymorphisms. Ann. N Y Acad. Sci. 815, 282-295 (1997).
41. van der Pol, W. & van de Winkel, J. G. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 48, 222-232 (1998).
42. Tan Sardjono, C., Mottram, P. L. & Hogarth, P. M. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell. Biol. 81, 374-381 (2003).
43. Falanga, Y. T. et al. Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J. Immunol. 188, 4360-4368 (2012).
44. Odom, S. et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199, 1491-1502 (2004).
45. Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I. & Yamamoto, T. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187, 1343-1348 (1998).
46. Stamatiades, E. G. et al. Immune monitoring of trans-endothelial transport by kidney-resident macrophages. Cell 166, 991-1003 (2016).
47. Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277 (1982).
48. Shang, L. et al. Selective antibody intervention of Toll-like receptor 4 activation through Fc gamma receptor tethering. J. Biol. Chem. 289, 15309-15318 (2014).
49. McAdoo, S. P. et al. Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression. Kidney Int. 88, 52-60 (2015).